These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23652216)

  • 1. The economic impact of multiple sclerosis in Australia in 2010.
    Palmer AJ; Colman S; O'Leary B; Taylor BV; Simmons RD
    Mult Scler; 2013 Oct; 19(12):1640-6. PubMed ID: 23652216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of multiple sclerosis in Australia.
    Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
    J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of multiple sclerosis in the Czech Republic: the COMS study.
    Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
    Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect economic consequences of multiple sclerosis in Ireland.
    Fogarty E; Walsh C; McGuigan C; Tubridy N; Barry M
    Appl Health Econ Health Policy; 2014 Dec; 12(6):635-45. PubMed ID: 25227118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.
    Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T
    BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T; Palmer AJ
    Mult Scler Relat Disord; 2020 Sep; 44():102247. PubMed ID: 32554286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.
    Karampampa K; Gustavsson A; van Munster ET; Hupperts RM; Sanders EA; Mostert J; Sinnige OL; de Graaf J; Pop P; Miltenburger C; Groot MT; Relleke M; van der Hel WS
    J Med Econ; 2013 Jul; 16(7):939-50. PubMed ID: 23692584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of intangible costs to the economic burden of multiple sclerosis.
    Wundes A; Brown T; Bienen EJ; Coleman CI
    J Med Econ; 2010; 13(4):626-32. PubMed ID: 20950249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The socioeconomic consequences of multiple sclerosis: a controlled national study.
    Jennum P; Wanscher B; Frederiksen J; Kjellberg J
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):36-43. PubMed ID: 21669514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
    Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers.
    Parisé H; Laliberté F; Lefebvre P; Duh MS; Kim E; Agashivala N; Abouzaid S; Weinstock-Guttman B
    J Neurol Sci; 2013 Jul; 330(1-2):71-7. PubMed ID: 23647840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
    da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC
    BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden in a German cohort of patients with multiple sclerosis.
    Reese JP; John A; Wienemann G; Wellek A; Sommer N; Tackenberg B; Balzer-Geldsetzer M; Dodel R
    Eur Neurol; 2011; 66(6):311-21. PubMed ID: 22086151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.